INSMED develops and sells medicines for serious lung diseases and other conditions, based in Bridgewater, New Jersey. It last closed at $121.86 on Nov 17, down 0.83% on the day. The average 12-month price target from 6 analysts is $204.50 (+67.8% from the last close), with a high of $220.00 and a low of $188.00. Analyst consensus is Strong Buy, based on the latest ratings from 6 firms (6 buy, 0 hold, 0 sell). Over the past 90 days StreetAlpha recorded 3 whale options trades in INSM, 100% of them bullish and 0% bearish. In the past 30 days there were 12 dark pool prints totaling $10.1M, the largest $1.6M.
Each firm's latest rating on INSM in the past 90 days
Average 12-month target
$204.50
▲ 67.8% upside
Based on 6 analysts who set a price target on INSM in the past 90 days. The average target is $204.50, with a high of $220.00 and a low of $188.00, compared with the last close of $121.86.
Highest target$220.00
Average target$204.50
Lowest target$188.00
Latest rating changes
HC Wainwright & Co.Assumed coverage
Nov 4Buy$220
GuggenheimTarget lowered
Nov 2Buy$205 → $201
Morgan StanleyTarget raised
Oct 21Buy$212 → $213
HC Wainwright & Co.Reiterated
Oct 12Buy$220
BarclaysMaintained
Sep 30Buy$207
Date
Firm
Action
Rating
Price target
Nov 4
HC Wainwright & Co.
Assumed coverage
Buy
$220
Nov 2
Guggenheim
Target lowered
Buy
$205 → $201
Oct 21
Morgan Stanley
Target raised
Buy
$212 → $213
Oct 12
HC Wainwright & Co.
Reiterated
Buy
$220
Sep 30
Barclays
Maintained
Buy
$207
Loading…
Technical Analysis
INSM · as of the Nov 17 close · updated after every close
Bounce inside a longer downtrend, nearing overbought
The stock is 11% above its 20 day and 9% above its 50 day average. It is sitting right on its 200 day average, a level many traders watch. Momentum is strong (RSI 65), near overbought. The nearest support is the Pivot at $121.23, and the nearest resistance the 200 day average at $122.83.
Short trendBullish
Long trendBearish
MomentumStrong
StretchNear overbought
VolatilityHigh, 3.9%/day
Key levels
$212.7552 week high+74.6%
$123.93Pivot R1+1.7%
$122.90Swing high (Sep 25)+0.9%
$122.83200 day average+0.8%
$121.86Last close
$121.23Pivot−0.5%
$121.04Swing low (Sep 9)−0.7%
$119.17Pivot S1−2.2%
$113.41100 day average−6.9%
$110.6950 day average−9.2%
$108.9620 day average−10.6%
$90.3952 week low−25.8%
Indicators
RSI (14)
64.73
Strong, overbought above 70
Neutral
MACD
4.39
Above its signal line
Bullish
Stochastic
92.8
Near the top of its range
Overbought
ADX (14)
31.1
Trending up
Williams %R
-13.8
Oversold below −80, overbought above −20
Overbought
CCI (20)
97.5
Oversold below −100, overbought above 100
Neutral
Rate of change
+16.7%
Change over 10 sessions
Bullish
ATR (14)
$4.80
Typical daily range, 3.9% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Below
Rising
Short trendBullish
Long trendNot enough history
MomentumImproving
StretchNormal
VolatilityNormal, 9.7%/day
Key levels
$212.7552 week high+74.6%
$123.93Pivot R1+1.7%
$122.90Swing high (Sep 25)+0.9%
$122.83200 day average+0.8%
$121.86Last close
$121.23Pivot−0.5%
$121.04Swing low (Sep 9)−0.7%
$119.17Pivot S1−2.2%
$113.41100 day average−6.9%
$110.6950 day average−9.2%
$108.9620 day average−10.6%
$90.3952 week low−25.8%
Indicators
RSI (14)
52.60
Middle of its range
Neutral
MACD
-3.02
Above its signal line
Bullish
Stochastic
63.6
Middle of its range
Neutral
ADX (14)
14.3
No clear trend
Williams %R
-24.0
Oversold below −80, overbought above −20
Neutral
CCI (20)
56.6
Oversold below −100, overbought above 100
Neutral
Rate of change
−5.8%
Change over 10 sessions
Bearish
ATR (14)
$11.87
Typical daily range, 9.7% of price
MA 10Above
MA 20Above
MA 50Below
MA 100Above
MA 200–
What happened before, for INSM
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how INSM did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Whale flow leans bullish3 bullish and 0 bearish whale options trades in the last 90 days. See Whale Flow
November seasonalityHow INSM usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How INSM has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether INSM is in one of them and how their past INSM trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About INSMED
INSMED is a biopharmaceutical company based in Bridgewater, New Jersey. It develops and sells medicines for serious diseases, with a focus on lung conditions. Its two marketed products are ARIKAYCE, an inhaled treatment for lung disease caused by MAC, and BRINSUPRI, an oral tablet for bronchiectasis, a chronic lung disease. Its other programs target pulmonary hypertension, an immune condition called hidradenitis suppurativa, and neurological diseases such as Duchenne muscular dystrophy and ALS. Its patients are people living with these conditions.